Petros Pharmaceuticals, Inc. Repayments of Senior Debt
Petros Pharmaceuticals, Inc. (PTPI) reported Repayments of Senior Debt of $6.65 million for the 12-month period ending 2021-12-31, per its 10-K filed 2023-03-31.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfSeniorDebt · last filed 2023-03-31
- Petros Pharmaceuticals, Inc. repayments of senior debt for the quarter ending 2021-12-31 was $1.74M.
- Petros Pharmaceuticals, Inc. repayments of senior debt for the quarter ending 2021-09-30 was $1.68M.
- Petros Pharmaceuticals, Inc. repayments of senior debt for the quarter ending 2021-06-30 was $1.64M.
- Petros Pharmaceuticals, Inc. repayments of senior debt for the quarter ending 2021-03-31 was $1.59M.
- Petros Pharmaceuticals, Inc. repayments of senior debt for fiscal 2021 was $6.65M.
| Period end | Repayments of Senior Debt 3 month | Repayments of Senior Debt 6 month | Repayments of Senior Debt 9 month | Repayments of Senior Debt 12 month |
|---|---|---|---|---|
| 2021-12-31 | $1.74M derived: 10-K 12 month − 10-Q/A 9 month · filed 2023-03-31 | $3.43M derived: sum of 2 quarters · filed 2023-03-31 | $5.06M derived: sum of 3 quarters · filed 2023-03-31 | $6.65M 10-K · filed 2023-03-31 |
| 2021-09-30 | $1.68M derived: 10-Q/A 9 month − 10-Q 6 month · filed 2022-11-15 | $3.32M derived: sum of 2 quarters · filed 2022-11-15 | $4.91M 10-Q/A · filed 2022-11-15 | |
| 2021-06-30 | $1.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $3.23M 10-Q · filed 2022-08-12 | ||
| 2021-03-31 | $1.59M 10-Q · filed 2022-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B |